Showing results (2311-2320 of 2,689) with videos related to
Sort By:
Pageof 269
American Journal of Respiratory and Critical Care Medicine|March 15, 2022
Stakeholder Research Priorities to Promote Implementation of Shared Decision-Making for Lung Cancer Screening: An American Thoracic Society and Veterans Affairs Health Services Research and Development StatementRenda Soylemez Wiener, Anna M Barker, Lisa Carter-Harris, et al.International Journal of Cancer|October 25, 2011
CDH1-related hereditary diffuse gastric cancer syndrome: clinical variations and implications for counselingIrma Kluijt, Ester J M Siemerink, Margreet G E M Ausems, et al.The Plant Journal : for Cell and Molecular Biology|July 8, 2000
T-DNA insertional mutagenesis for functional genomics in riceJ S Jeon, S Lee, K H Jung, et al.BMC Genomics|October 18, 2005
Macrodissection versus microdissection of rectal carcinoma: minor influence of stroma cells to tumor cell gene expression profilesElza C de Bruin, Simone van de Pas, Esther H Lips, et al.European Journal of Endocrinology|September 22, 2025
Natural history of nonfunctioning pituitary microadenomas: a systematic review and individual participant data meta-analysisVictor B Boesen, Tue H Hansen, Mohammad Motawea, et al.Cell Reports|June 8, 2025
Cholesterol metabolism regulated by CAMKK2-CREB signaling promotes castration-resistant prostate cancerChenchu Lin, Thomas L Pulliam, Jenny J Han, et al.Scientific Reports|August 28, 2024
Functional prediction of response to therapy prior to therapeutic intervention is associated with improved survival in patients with high-grade gliomaAubrey Ledford, Analiz Rodriguez, Lindsay Lipinski, et al.Plos One|March 7, 2012
Transcriptome and network changes in climbers at extreme altitudesFang Chen, Wei Zhang, Yu Liang, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2024
Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic castration-resistant prostate cancerD E Rathkopf, M R Patel, A D Choudhury, et al.Cancer|March 21, 2014
Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium ProgramChi Young Ok, Zijun Y Xu-Monette, Alexandar Tzankov, et al.Pageof 269